QUELICIN — Class II drug recall D-0953-2017
Terminated recall by Advanced Pharma Inc., reported 2017-07-19, distributed nationwide. Lack of Assurance of Sterility
| Recall number | D-0953-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Advanced Pharma Inc., Houston, TX, United States |
| Recall initiated | 2017-06-22 |
| Classified | 2017-07-07 |
| Reported by FDA | 2017-07-19 |
| Terminated | 2017-12-06 |
| Distributed | Nationwide (US) |
| Quantity | 2,350 units |
| Reason classes | sterility |
| NDC | 15082-0814-61, 15082-0814-67, 15082-0814-79 |
| Expiration dates | 2017-07-15, 2017-07-17, 2017-07-23, 2017-07-29, 2017-08-04, 2017-08-05, 2017-08-13, 2017-08-26 |
Product
QUELICIN (Succinylcholine Chloride) Injection, USP 20 mg/mL in a) 5 mL vial (NDC 15082-814-67), b) 7mL vial (NDC 15082-814-79), c) 10mL vial (NDC 15082-814-61), Repackaged by Advanced Pharm, 9265 Kirby Dr., Houston, TX 77054 (877) 794-0404.
Reason for recall
Lack of Assurance of Sterility
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0953-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.